Cystadrops is an ophthalmic solution containing cysteamine. The active ingredient is cysteamine, and inactive ingredients are carmellose sodium, citric acid monohydrate, disodium edetate dihydrate, hydrochloric acid, sodium hydroxide, and water. Cysteamine acts as a cystine-depleting agent by converting cystine to cysteine and cysteinecysteamine mixed disulfides and reduces corneal cystine crystal accumulation.
Professionals recommend Cystadrops for corneal cystine crystal deposits in adults and children with cystinosis. Cystinosis is a lysosomal storage disease, and an indication of this disease is the abnormal accumulation of cystine, the oxidized dimer of the amino acid cysteine. Cystinosis is a genetic disorder that follows an autosomal recessive inheritance pattern.
Cysteamine eye drops contain 3.8 mg/ml of cysteamine. This medicine comes in a 10 ml amber glass bottle.
Dosage and Administration
Description of dosage
Preparation and administration
There is no case of an overdose of CYSTEAMINE ophthalmic, but consult the doctor for worsening signs and symptoms if any patient takes an overdose.
Every medicine has some side effects, and this medicine also has numerous side effects, which are categorized as:
Note: Not every patient has these side effects; if any patient experiences the symptoms mentioned above or any other, consult the doctor immediately.
Contamination of solution and tips
To avoid the contamination of the dropper tip and solution, one should take care not to touch the eyelids or surrounding areas with the bottle’s dropper tip. Keep the bottle tightly closed when not in use.
There are reports of benign intracranial hypertension, also known as pseudotumor cerebri, associated with oral cysteamine treatment that has resolved with the addition of diuretic therapy. There are also reports associated with ophthalmic use of cysteamine; however, all of these patients were on concurrent oral cysteamine.
Use of contact lens
Cystadrops contain benzalkonium chloride, which soft contact lenses may absorb. Avoid contact with soft contact lenses, and one should remove the contact lenses before applying the solution, and one can reinsert the solution 15 minutes following its administration.
Cysteamine ophthalmic solution 0.37% comes as a 5 ml sterile viscous solution in a 10 ml amber glass bottle closed by a bromobutyl stopper and sealed with an aluminum tear-off cap. A PVC dropper applicator with HDPE closure is packed separately and included in each carton box.
Each carton box contains 1 bottle and 1 dropper applicator individually wrapped.
Before First Opening: Before opening, store new, unopened medicine in the refrigerator between 36°F-46°F or 2°C-8°C. And to protect the drug from light, keep the bottle in the outer carton.
After First Opening: After opening, the store opened the medicine at room temperature between 68°F-77°F or 20°C-25°C. Do not refrigerate after opening. Keep the dropper bottle tightly closed in the outer carton to protect it from light. Discard 7 days after the first opening.
Cystadrops is an ophthalmic solution containing cysteamine. Professionals recommend Cystadrops for corneal cystine crystal deposits in adults and children with cystinosis.
Cystadrops contain cysteamine as an active ingredient and carmellose sodium, citric acid monohydrate, disodium edetate dihydrate, hydrochloric acid, and sodium hydroxide and water as inactive ingredients.
Recordati is the innovator, and Ikris Pharma Network is an authorized partner of it, who can help access this medicine in India for the patient through legal procedure. To know Cystadrops price and more, contact Ikris at toll-free no. 18008891064 or write at email@example.com.
In India, you can buy this medicine with the help of Ikris Pharma Network, an authorized partner of “Recordati” for this medicine.